Ditch et al. [13, 24] found an inverse association between THRα-2 and tumor size, lymph node involvement, histological grade and hormone receptor expression, and an improved disease-free survival among 82 women with higher tumor-specific THRα-2 levels. The gene discussed is NR4A1; the disease is neoplasm.